MATN Stock Price, News & Analysis
MATN
OTC
Company Description
MATN (OTC: MATN) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.
MATN stock has declined 56.8% over the past year.
This page provides a comprehensive overview of MATN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-56.75%
Performance 1 year
$0.0
MATN (MATN) stock. Over the past 12 months, the stock has lost 56.8%.
Latest News
MATN has 10 recent news articles. Key topics include clinical trial, covid-19, AI, conferences. View all MATN news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
MATN Company Profile & Sector Positioning
MATN (MATN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.